Cargando…
Palliative chemotherapy in carcinoma nasopharynx
INTRODUCTION: Nasopharyngeal carcinoma is a rare malignancy. We conducted an audit of systemic therapies received in palliative setting in carcinoma nasopharynx and studied their outcomes. METHODS: Patients who underwent first-line palliative systemic chemotherapy between January 2014 and April 2017...
Autores principales: | Patil, Vijay M., Joshi, Amit, Noronha, Vanita, Talreja, Vikas, Simha, Vijai, Dhumal, Sachin, Bandekar, Bhavesh, Chandrasekharan, Arun, Prabhash, Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699237/ https://www.ncbi.nlm.nih.gov/pubmed/31489292 http://dx.doi.org/10.4103/sajc.sajc_230_18 |
Ejemplares similares
-
Metronomic palliative chemotherapy in maxillary sinus tumor
por: Patil, Vijay M., et al.
Publicado: (2016) -
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients
por: Patil, Vijay, et al.
Publicado: (2018) -
A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers
por: Noronha, Vanita, et al.
Publicado: (2017) -
Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
por: Patil, Vijay M., et al.
Publicado: (2016) -
Role of neoadjuvant chemotherapy in advanced carcinoma of the hypopharynx and larynx
por: Joshi, Poonam, et al.
Publicado: (2017)